CardioMend Overview

  • Founded
  • 1995
  • Status
  • Private
  • Employees
  • 7
  • Latest Deal Type
  • 2ndary - Private

CardioMend General Information


Provider of surgical instruments for heart valve reconstruction. The company provides a technology which allows a cardiac surgeon to reconstruct a diseased aortic or pulmonary heart valve using the patient's own tissue.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Medical Supplies
Other Industries
Other Devices and Supplies
Surgical Devices
Primary Office
  • 2410 Fletcher Avenue
  • Suite 101
  • Santa Barbara, CA 93108
  • United States
+1 (805) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

CardioMend Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Secondary Transaction - Private 01-Jan-2007 Completed Generating Revenue
3. Later Stage VC 01-Oct-2002 Completed Generating Revenue
2. Grant 01-Jan-2000 $483K Completed Startup
1. Grant 01-Jan-1998 $100K Completed Startup
To view CardioMend’s complete valuation and funding history, request access »

CardioMend Patents

CardioMend Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20060020280-A1 Surgical cutting device Granted 23-Jul-2004 000000000000 0
US-7208000-B2 Surgical cutting device Expired - Fee Related 23-Jul-2004 000000000000 0
EP-1427324-A1 Device and method for assessing the geometry of a heart valve Withdrawn 13-Aug-2001 0000000000
US-6425902-B1 Surgical instrument for heart valve reconstruction Expired - Lifetime 04-May-2001 0000000000 00
EP-1387652-A1 Surgical instrument for heart valve reconstruction Withdrawn 04-May-2001 A61F2/2427
To view CardioMend’s complete patent history, request access »

CardioMend Executive Team (1)

Name Title Board Seat Contact Info
Jack Love MD Founder, Chief Executive Officer & Chief Scientific Officer
To view CardioMend’s complete executive team members history, request access »

CardioMend Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial